PRESCRIPTIVES

Product NDC: 59158-913
11-digit product format: 591580913
Labeler code: 59158
Product ID: 59158-913_32cbe570-53c5-4835-a17c-8cea24909895
Type: HUMAN OTC DRUG
Nonproprietary name: OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE
Dosage form: LIQUID
Route: TOPICAL
Labeler: PRESCRIPTIVES INC.
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2006-11-16
Marketing end: 0000-00-00
Substance: OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
Active strength: 0 g/mL; g/mL; g/mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	59158-913		I	Inactivated by FDA		2026-11-13
excluded package	package	59158-913	59158-913-01	I	Inactivated by FDA		2026-11-13

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59158-913-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59158-913-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59158-913-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59158-913-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59158-913-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59158-913-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59158-913-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59158-913-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59158-913-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59158-913-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59158-913-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59158-913-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	59158-913-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	59158-913-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	59158-913-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	59158-913-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	59158-913-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	59158-913-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	59158-913-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	59158-913-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	59158-913-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	59158-913-01	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59158-913-01	2020-01-31	C162847	48780-1	9d75b9d1-1728-f424-e053-dadaa90a57ce	PRESCRIPTIVES Site Unseen Brightening Concealer Broad Spectrum SPF 15

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59158-913-01	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15	1 in 1 CARTON	LIQUID	1		1
59158-913-01	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15	3.5 mL in 1 TUBE	LIQUID	3.5		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
ACETYL HEXAPEPTIDE-8	INACTIVE INGREDIENT	L4EL31FWIL	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
CHLOROXYLENOL	INACTIVE INGREDIENT	0F32U78V2Q	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
HESPERIDIN METHYLCHALCONE	INACTIVE INGREDIENT	4T2GVA922X	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
ISOPROPYL TITANIUM TRIISOSTEARATE	INACTIVE INGREDIENT	949E3KBJ1I	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
MAGNESIUM SULFATE	INACTIVE INGREDIENT	DE08037SAB	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
MATRICARIA RECUTITA	INACTIVE INGREDIENT	G0R4UBI2ZZ	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
MICA	INACTIVE INGREDIENT	V8A1AW0880	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
OCTYLDODECYL NEOPENTANOATE	INACTIVE INGREDIENT	X8725R883T	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
PALMITOYL TETRAPEPTIDE-7	INACTIVE INGREDIENT	Q41S464P1R	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
PEG/PPG-18/18 DIMETHICONE	INACTIVE INGREDIENT	9H0AO7T794	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
PHENYL TRIMETHICONE	INACTIVE INGREDIENT	DR0K5NOJ4R	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
SORBITAN SESQUIOLEATE	INACTIVE INGREDIENT	0W8RRI5W5A	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
STEARETH-20	INACTIVE INGREDIENT	L0Q8IK9E08	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
TRIETHOXYCAPRYLYLSILANE	INACTIVE INGREDIENT	LDC331P08E	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
VALYLTRYPTOPHAN	INACTIVE INGREDIENT	3G64B4AFQN	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1
YEAST	INACTIVE INGREDIENT	3NY3SM6B8U	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59158-913	PRESCRIPTIVES SITE UNSEEN BRIGHTENING CONCEALER BROAD SPECTRUM SPF 15 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LIQUID [PRESCRIPTIVES INC.]	1	Legacy NDC, 2 package rows	20121120_d0f13a8f-bfe1-475c-b001-ae1d1274a633.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
15FIX9V2JP	TITANIUM DIOXIDE	13463-67-7	TITANIUM DIOXIDE
SOI2LOH54Z	ZINC OXIDE	1314-13-2	ZINC OXIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
59158-913-01	59158091301	1 in 1 CARTON	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
PRESCRIPTIVES Site Unseen Brightening Concealer Broad Spectrum SPF 15	PRESCRIPTIVES INC. \| ELGC K.K. \| Estee Lauder Pennsylvania Distribution Center 2 (PADC 2) \| Estee Lauder Inc. \| ESTEE LAUDER COSMETICS DISTRIBUTION CENTER \| ESTEE LAUDER COSMETICS, LTD \| ESTEE LAUDER COSMETICS, LTD. \| ESTEE LAUDER N.V. \| LEN-RON MANUFACTURING DIVISION OF ARAMIS INC \| NORTEC KEYSTONE \| NORTHTEC BRISTOL \| NORTHTEC KEYSTONE \| WHITMAN LABORATORIES, LTD. \| Aveda Corporation \| Pennsylvania Logistics Center	2012-11-15	HUMAN OTC DRUG LABEL	1